GAIN AI Act of 2025
The source supplies the latest action, but no lifecycle stage.
Latest action (6 Nov 2025): Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
What this bill does
The GAIN AI Act of 2025, if passed, would amend export control laws regarding advanced artificial intelligence (AI) chips. Specifically, it would require companies seeking to export these chips to countries designated as "countries of concern" to certify that U.S. persons have been given priority in purchasing them. This certification would involve demonstrating that U.S. entities were offered a right of first refusal and did not face disadvantages in pricing or terms compared to foreign buyers.
This bill primarily affects entities involved in the export of advanced AI chips and U.S. persons who purchase these chips. It would establish a licensing requirement for exporting covered AI chips to countries of concern. The bill also outlines conditions and requirements for U.S. persons to receive preference, including offering a right of first refusal and ensuring no existing backlog of orders from U.S. customers or foreseeable negative impact on U.S. production capacity.
The bill was introduced in the Senate and has been referred to the Committee on Banking, Housing, and Urban Affairs. If it moves forward, it would require approval by the Senate, then the House of Representatives, and finally be signed into law by the President. The bill also mandates that the Under Secretary of Commerce for Industry and Security implement regulations and seek public input within 90 days of enactment.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
6 Nov 2025
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Common questions
- What does S. 3150 do?
- The GAIN AI Act of 2025, if passed, would amend export control laws regarding advanced artificial intelligence (AI) chips. Specifically, it would require companies seeking to export these chips to countries designated as "countries of concern" to certify that U.S. persons have been given priority in purchasing them. This certification would involve demonstrating that U.S. entities were offered a right of first refusal and did not face disadvantages in pricing or terms compared to foreign buyers. This bill primarily affects entities involved in the export of advanced AI chips and U.S. persons who purchase these chips. It would establish a licensing requirement for exporting covered AI chips to countries of concern. The bill also outlines conditions and requirements for U.S. persons to receive preference, including offering a right of first refusal and ensuring no existing backlog of orders from U.S. customers or foreseeable negative impact on U.S. production capacity. The bill was introduced in the Senate and has been referred to the Committee on Banking, Housing, and Urban Affairs. If it moves forward, it would require approval by the Senate, then the House of Representatives, and finally be signed into law by the President. The bill also mandates that the Under Secretary of Commerce for Industry and Security implement regulations and seek public input within 90 days of enactment.
- Has S. 3150 become law?
- The source does not supply a confirmed lifecycle stage for S. 3150. Check the latest action and official source below.
- Who sponsored S. 3150?
- S. 3150 was sponsored by Sen. Banks, Jim [R-IN] (R-IN), with 5 cosponsors.
- What's the latest action on S. 3150?
- Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. (6 Nov 2025).
Related bills in Foreign Trade and International Finance
Tariff Relief for American Development and Employment Act of 2026
Ecuador Shrimp Tariff Act
Connected Vehicle Security Act of 2026
BEEF Act
More bills from Sen. Banks, Jim [R-IN]
Electric Grid Supply Chain Security Act
A bill to amend the Higher Education Act of 1965 to require that recipients of Pell Grants be citizens or nationals of the United States.
Accountable Produce is Medicine Act of 2026
Prescription Information Modernization Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.